Curia’s NHS Innovation and Life Sciences Commission Co-Chair, Lord O’Shaughnessy to Lead Independent Review into UK Clinical Trials
Government commissions independent commercial clinical trials review from Lord James O’Shaughnessy.
Government commissions independent commercial clinical trials review from Lord James O’Shaughnessy.
The Government has announced a new strategy to boost access to medtech innovations in the UK, we examine the outlook for the sector and patients from the new plans.
In recognition of World Cancer Day, we partnered with thought leaders across the NHS, civil society and life sciences to discuss breast cancer and improvement to care pathways.
Our partners, Lilly are calling for the Government to freeze the statutory scheme repayment rate for 2023, in a bid to ensure growth in the UK pharmaceutical industry.
Tens of thousands of elderly and vulnerable people will receive tailored support at home as part of a new out of hospital NHS plan to improve waiting times for emergency care.
The UK is looking to introduce first-of-its-kind framework to make it easier to manufacture invest in innovation for medicines at the point of care.
The Government has pledged £10 million to speed up breast cancer diagnosis and treatment.
In recognition of National Obesity Awareness Week, we partnered with thought leaders across the NHS, civil society and life sciences to discuss obesity and improvement to care pathways.
New clinical cancer trials to begin using personalised treatment to save lives.
2023 sees the launch of a new treatment for breast cancer to augment existing radiotherapy techniques: Proton Beam Therapy.
Writing on the importance of levelling health inequalities across the UK, Lilly’s Laura Steele outlines the widening social determinants of health and potential solutions.
At the launch of Curia’s NHS Innovation and Life Sciences Commission, the chairs hosted a panel discussion, in partnership with Chamber UK, to talk about the biggest issues facing the health and life science sector.
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.